H. Bodenstein

3.4k total citations
39 papers, 1.8k citations indexed

About

H. Bodenstein is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, H. Bodenstein has authored 39 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 14 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in H. Bodenstein's work include Acute Myeloid Leukemia Research (17 papers), Multiple Myeloma Research and Treatments (6 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers). H. Bodenstein is often cited by papers focused on Acute Myeloid Leukemia Research (17 papers), Multiple Myeloma Research and Treatments (6 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers). H. Bodenstein collaborates with scholars based in Germany, Austria and United Kingdom. H. Bodenstein's co-authors include U. Karbach, Klaus Ewe, M. Planker, U. Vanhoefer, Harry Bleiberg, Bernard Nordlinger, Philippe Rougier, B Paillot, H. Wilke and Benoît Baron and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gut.

In The Last Decade

H. Bodenstein

39 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Bodenstein Germany 17 702 699 667 378 353 39 1.8k
Anne Lennard United Kingdom 20 414 0.6× 561 0.8× 167 0.3× 218 0.6× 154 0.4× 51 1.6k
P H Wiernik United States 23 441 0.6× 847 1.2× 318 0.5× 369 1.0× 253 0.7× 70 1.8k
R S Cox United States 20 255 0.4× 712 1.0× 747 1.1× 132 0.3× 174 0.5× 25 2.1k
Krzysztof Warzocha Poland 26 614 0.9× 672 1.0× 190 0.3× 518 1.4× 327 0.9× 169 2.6k
Ho‐Jin Shin South Korea 22 944 1.3× 655 0.9× 234 0.4× 399 1.1× 192 0.5× 182 2.0k
Daniele Laszlò Italy 20 597 0.9× 709 1.0× 180 0.3× 94 0.2× 188 0.5× 67 1.6k
Barbara Weinstein United States 20 1.0k 1.4× 373 0.5× 209 0.3× 214 0.6× 122 0.3× 50 1.8k
Donna L. Forrest Canada 27 1.4k 2.0× 482 0.7× 194 0.3× 422 1.1× 292 0.8× 110 2.3k
Réda Bouabdallah France 28 1.5k 2.1× 2.0k 2.9× 347 0.5× 880 2.3× 307 0.9× 101 4.0k
B Desablens France 23 854 1.2× 744 1.1× 277 0.4× 346 0.9× 331 0.9× 89 2.6k

Countries citing papers authored by H. Bodenstein

Since Specialization
Citations

This map shows the geographic impact of H. Bodenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Bodenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Bodenstein more than expected).

Fields of papers citing papers by H. Bodenstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Bodenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Bodenstein. The network helps show where H. Bodenstein may publish in the future.

Co-authorship network of co-authors of H. Bodenstein

This figure shows the co-authorship network connecting the top 25 collaborators of H. Bodenstein. A scholar is included among the top collaborators of H. Bodenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Bodenstein. H. Bodenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Röllig, Christoph, Matthias Hänel, Michael Krämer, et al.. (2014). Two cycles of risk-adapted consolidation therapy in patients with acute promyelocytic leukemia. Results from the SAL-AIDA2000 trial. Annals of Hematology. 94(4). 557–563. 5 indexed citations
2.
3.
Stölzel, Friedrich, Markus Pfirrmann, Walter E. Aulitzky, et al.. (2010). Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trial. Leukemia. 25(3). 420–428. 21 indexed citations
4.
Röllig, Christoph, Christian Thiede, Martin Gramatzki, et al.. (2010). A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial. Blood. 116(6). 971–978. 118 indexed citations
5.
6.
Rummel, Mathias, H. Bodenstein, M. Baldus, et al.. (2008). Efficacy and safety of bendamustine and rituximab in the treatment of indolent and mantle cell lymphomas in older patients. Journal of Clinical Oncology. 26(15_suppl). 8572–8572. 10 indexed citations
7.
Kröger, Nicolaus, Oleg Gluz, Svjetlana Mohrmann, et al.. (2006). Randomized Trial of Single Compared With Tandem High-Dose Chemotherapy Followed by Autologous Stem-Cell Transplantation in Patients With Chemotherapy-Sensitive Metastatic Breast Cancer. Journal of Clinical Oncology. 24(24). 3919–3926. 10 indexed citations
8.
Glasmacher, Axel, Oliver A. Cornely, Andrew J. Ullmann, et al.. (2005). An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia. Journal of Antimicrobial Chemotherapy. 57(2). 317–325. 69 indexed citations
9.
Repp, Roland, Christian Thiede, Silke Soucek, et al.. (2003). Immunophenotyping is an independent factor for risk stratification in AML. Cytometry Part B Clinical Cytometry. 53B(1). 11–19. 33 indexed citations
10.
11.
Köhne, C.-H., Hans‐Joachim Wilke, Wolfgang Hiddemann, et al.. (1997). Phase II Evaluation of 5-Fluorouracil plus Folonic Acid and Alpha 2b-lnterferon in Metastatic Colorectal Cancer. Oncology. 54(2). 96–101. 8 indexed citations
12.
Haase, Dagmar, et al.. (1995). Cytogenetic findings in 179 patients with myelodysplastic syndromes. Annals of Hematology. 70(4). 171–187. 3 indexed citations
13.
Haase, Dagmar, Christa Fonatsch, Mathias Freund, et al.. (1995). Cytogenetic findings in 179 patients with myelodysplastic syndromes. Annals of Hematology. 70(4). 171–187. 68 indexed citations
14.
Rieder, Harald, Susanne Schnittger, H. Bodenstein, et al.. (1995). dic(9; 20): A new recurrent chromosome abnormality in adult acute lymphoblastic leukemia. Genes Chromosomes and Cancer. 13(1). 54–61. 34 indexed citations
15.
Wessalowski, R., H. Jürgens, H. Bodenstein, et al.. (1988). Behandlungsergebnisse beim primär metastasierten Ewing-Sarkom Eine retrospektive Analyse von 48 Patienten. Klinische Pädiatrie. 200(3). 253–260. 21 indexed citations
16.
Freund, Mathias, et al.. (1985). Treatment of Acute Myelocytic Leukemia with a Daunorubicin-Cytarabine-6 Thioguanine Regimen without Maintenance Therapy. Oncology Research and Treatment. 8(3). 150–152. 2 indexed citations
17.
Karbach, U., Klaus Ewe, & H. Bodenstein. (1983). Alpha 1-antitrypsin, a reliable endogenous marker for intestinal protein loss and its application in patients with Crohn's disease.. Gut. 24(8). 718–723. 83 indexed citations
18.
Bodenstein, H., et al.. (1976). Kolonie-stimulierende Aktivit�t (CSA) in Urin und Serum bei einem Kind mit zyklischer Neutropenie. Annals of Hematology. 32(4). 285–288. 1 indexed citations
19.
Arndt, D., M. R. Parwaresch, & H. Bodenstein. (1975). Autoradiographische Darstellung der basophilen Granulozyten des Menschen. Annals of Hematology. 30(3). 199–202. 2 indexed citations
20.
Bodenstein, H.. (1970). Karyometrische Untersuchungen im Schnittpräparat des normalen menschlichen Knochenmarks. Annals of Hematology. 20(3). 137–148. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Lennard Breakdown of academic impact, for papers by P H Wiernik Breakdown of academic impact, for papers by R S Cox Breakdown of academic impact, for papers by Krzysztof Warzocha Breakdown of academic impact, for papers by Ho‐Jin Shin Breakdown of academic impact, for papers by Daniele Laszlò Breakdown of academic impact, for papers by Barbara Weinstein Breakdown of academic impact, for papers by Donna L. Forrest Breakdown of academic impact, for papers by Réda Bouabdallah Breakdown of academic impact, for papers by B Desablens
Rankless by CCL
2026